Kevin Yu, DO
Nephrology · Las Vegas, NVNPI 1417395609
Payments from drug & device makers
Across 11 payments — averaging $59.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomerieux Inc$442
- Vifor Pharma, Inc.$35
- Aurinia Pharma U.S., Inc.$29
- Amgen$26
- Mallinckrodt Hospital Products Inc.$25
- GSK$24
- plus $73 from 4 others
What the payments were for
- Consulting fees$44268%
- Food & beverage$21132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomerieux Inc | 1 | $442 |
| Vifor Pharma, Inc. | 2 | $35 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Amgen | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| GSK | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $20 |
| Novartis | 1 | $17 |
| Nxstage Medical, Inc. | 1 | $14 |
How this compares
$653 in reported general payments places this provider in the 25th percentile of 125 nephrology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 24 | $20,737 |
| FarxigaDapagliflozin Propanediol | 15 | $13,901 |
| ProsolParenteral Amino Acid 20% No.1 | 51 | $9,828 |
| Nifedipine ErNifedipine | 13 | $249 |
| Metoprolol Succinate | 16 | $188 |
| Amlodipine Besylate | 37 | $144 |
| Lisinopril | 25 | $108 |
| Furosemide | 31 | $81 |
| Losartan Potassium | 27 | $60 |
| Tamsulosin Hcl | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Las Vegas
- Mark VishnepolskyLas Vegas$11.3M
- Raj SinghLas Vegas$9.9M
- Samuel KantorLas Vegas$1M
- Jeffrey RyuLas Vegas$422K
- Lawrence LehrnerLas Vegas$239K
- Richard CottieroLas Vegas$220K
- Kamron SaleemLas Vegas$195K
- Mark AdaimyLas Vegas$142K
- Vincent YangLas Vegas$135K
- Prateek SangheraLas Vegas$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.